Carroll v. United States

Court of Appeals for the Second Circuit·Decided May 28, 2026·No. 25-1647·Unpublished

Opinion

25-1647 Carroll v. United States

UNITED STATES COURT OF APPEALS FOR THE SECOND CIRCUIT

SUMMARY ORDER

RULINGS BY SUMMARY ORDER DO NOT HAVE PRECEDENTIAL EFFECT. CITATION TO A SUMMARY ORDER FILED ON OR AFTER JANUARY 1, 2007, IS PERMITTED AND IS GOVERNED BY FEDERAL RULE OF APPELLATE PROCEDURE 32.1 AND THIS COURT’S LOCAL RULE 32.1.1. WHEN CITING A SUMMARY ORDER IN A DOCUMENT FILED WITH THIS COURT, A PARTY MUST CITE EITHER THE FEDERAL APPENDIX OR AN ELECTRONIC DATABASE (WITH THE NOTATION “SUMMARY ORDER”). A PARTY CITING TO A SUMMARY ORDER MUST SERVE A COPY OF IT ON ANY PARTY NOT REPRESENTED BY COUNSEL.

At a stated term of the United States Court of Appeals for the Second Circuit, held at the Thurgood Marshall United States Courthouse, 40 Foley Square, in the City of New York, on the 28th day of May, two thousand twenty-six.

PRESENT: RICHARD C. WESLEY, RICHARD J. SULLIVAN, JOSEPH F. BIANCO, Circuit Judges. _____________________________________

ROBERT CARROLL,

Plaintiff-Appellant,

v. No. 25-1647

UNITED STATES OF AMERICA,

Defendant-Appellee.

_____________________________________ For Plaintiff-Appellant: Robert Carroll, pro se, Connelly, NY.

For Defendant-Appellee: Karen Folster Lesperance, Assistant United States Attorney, for John A. Sarcone III, Acting United States Attorney for the Northern District of New York, Albany, NY.

Appeal from a judgment of the United States District Court for the Northern

District of New York (Lawrence E. Kahn, Judge).

UPON DUE CONSIDERATION, IT IS HEREBY ORDERED,

ADJUDGED, AND DECREED that the judgment of the district court is

AFFIRMED.

Robert Carroll, proceeding pro se, appeals from the district court’s dismissal

of his complaint for lack of subject-matter jurisdiction and its denial of his request

to file a second amended complaint. In essence, Carroll alleges that the staff of

the Samuel S. Stratton Department of Veterans Affairs Medical Center in Albany,

New York failed to diagnose and treat a cyst that led to medical complications, in

violation of the Federal Tort Claims Act (“FTCA”), 28 U.S.C. §§ 1346(b) and 2671

2680. We assume the parties’ familiarity with the underlying facts, procedural

2 history, and issues on appeal, to which we refer only as necessary to explain our

decision.

“When reviewing the dismissal of a complaint for lack of subject[-]matter

jurisdiction, we review factual findings for clear error and legal conclusions de

novo, accepting all material facts alleged in the complaint as true and drawing all

reasonable inferences in the plaintiff’s favor.” Liranzo v. United States, 690 F.3d 78,

84 (2d Cir. 2012). And “when denial of leave to file a revised [complaint] is based

on a legal interpretation, such as futility, a reviewing court conducts a de novo

review.” Balintulo v. Ford Motor Co., 796 F.3d 160, 164 (2d Cir. 2015). Finally,

because Carroll “has been pro se throughout,” we construe “his pleadings and

other filings . . . to raise the strongest claims they suggest.” Sharikov v. Philips

Med. Sys. MR, Inc., 103 F.4th 159, 166 (2d Cir. 2024).

As a sovereign nation, the United States – and its departments and agencies

– may not be sued without its consent. E.g., Maine Cmty. Health Options v. United

States, 590 U.S. 296, 322 (2020) (“The United States is immune from suit unless it

unequivocally consents.”). The FTCA provides a limited waiver of sovereign

immunity for claims seeking damages for injuries arising from the tortious

conduct of federal officers or agents acting within the scope of their office or

3 employment. 28 U.S.C. § 1346(b)(1); see also Makarova v. United States, 201 F.3d

110, 113 (2d Cir. 2000). But before suing under the FTCA, a plaintiff must exhaust

administrative remedies by “first present[ing] the claim to the appropriate federal

agency . . . within two years of the date the claim accrued.” Phillips v. Generations

Fam. Health Ctr., 723 F.3d 144, 147 (2d Cir. 2013); see 28 U.S.C. § 2401(b). The notice

of claim “must provide enough information to permit the agency to conduct an

investigation and to estimate the claim’s worth.” Romulus v. United States, 160

F.3d 131, 132 (2d Cir. 1998). And because the FTCA’s “requirement” to exhaust

administrative remedies “is jurisdictional and cannot be waived,” district courts

lack subject-matter jurisdiction whenever a plaintiff fails to exhaust those

remedies. Celestine v. Mount Vernon Neighborhood Health Ctr., 403 F.3d 76, 82 (2d

Cir. 2005).

Here, Carroll failed to exhaust his claims with the United States Department

of Veterans Affairs (“VA”) in a timely manner. While Carroll eventually filed a

notice of claim (an “SF-95”) with the VA in 2022, the notice attached to his original

complaint acknowledged on its face that Carroll learned of the previously

undiagnosed cyst that caused his injuries in 2018, when he had a second MRI and

was referred to a neurosurgeon. Because the SF-95 was filed more than four years

4 after the claim accrued in 2018, it was clearly untimely under the FTCA’s two-year

exhaustion requirement. See 28 U.S.C. § 2401(b); Ulrich v. Veterans Admin. Hosp.,

853 F.2d 1078, 1080 (2d Cir. 1988) (“An FTCA action accrues when the plaintiff in

the exercise of reasonable diligence knows both the existence and the cause of his

injury.”).

After commencing this lawsuit, Carroll changed his story, asserting that his

original SF-95 was mistaken and that he actually did not learn of the cyst – and the

VA’s alleged malpractice – until October 2020. See Dist. Ct. Doc. No. 8 at 7 (“The

plaintiff was not aware of the existence of the synovial cyst until the second lumbar

MRI performed on 10/23/2020”); id. at 8 (alleging that “the second MRI on

10/23/2020 [was] the earliest he could have suspected that the cyst was the cause

of the increasingly severe lower back pain and that the defendants had committed

medical malpractice.”). But even if we accept Carroll’s new chronology at face

value, his SF-95 was “received by” the VA “in November 2022,” id. at 12, which

was still more than two years after he learned of the cyst and came to believe “that

the defendants had committed medical malpractice,” id. at 8; see also id. at 3

(acknowledging that the VA received “plaintiff’s SF-95 in 11/2022” (emphasis

5 added)). 1 We therefore see no error in the district court’s dismissal of Carroll’s

claim.

Free access — add to your briefcase to read the full text and ask questions with AI

Carroll v. United States, (2d Cir. 2026).

Carroll v. United States (Carroll v. United States) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Natalia Makarova v. United States
201 F.3d 110 (Second Circuit, 2000)
Liranzo v. United States
690 F.3d 78 (Second Circuit, 2012)
Phillips v. Generations Family Health Center
723 F.3d 144 (Second Circuit, 2013)
Balintulo Ex Rel. Balintulo v. Ford Motor Co.
796 F.3d 160 (Second Circuit, 2015)
Cuoco v. Moritsugu
222 F.3d 99 (Second Circuit, 2000)
Cooke v. United States
918 F.3d 77 (Second Circuit, 2019)
Sharikov v. Philips Medical Systems MR, Inc.
103 F.4th 159 (Second Circuit, 2024)